Data compiled by Redley Lamar · ChainSifter Intelligence
9Suppliers
11Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Actinium Pharmaceuticals, Inc. (ATNM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
24Total relationships
4Distinct source URLs
11High confidence
0.800Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Actinium Pharmaceuticals, Inc. Suppliers
Ticker
Name
Confidence
Evidence
AC-225-AND-OTHER-RADIOISOTOPES-SUPPLIERS
AC-225-AND-OTHER-RADIOISOTOPES-SUPPLIERS
92%
We maintain supply agreements with multiple domestic and international suppliers of Ac-225 and other radioisotopes, providing priority access and redundancy to ensure reliable supply.
CONTRACT-MANUFACTURING-ORGANIZATIONS
CONTRACT-MANUFACTURING-ORGANIZATIONS
92%
We have qualified multiple contract manufacturers capable of producing our drug products under cGMP conditions.
RADIOPHARMACEUTICAL-LOGISTICS-PROVIDERS
RADIOPHARMACEUTICAL-LOGISTICS-PROVIDERS
92%
We have established relationships with specialized radiopharmaceutical logistics providers capable of cold-chain distribution, real-time tracking, and just-in-time delivery to clinical sites and comm…
Reciprocal relationship from CNSP graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from CNSP graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from CNSP g…
Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, ma…
Reciprocal relationship from DRTSW graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from DRTSW graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from DRTS…
Reciprocal relationship from JNJ graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from JNJ grap…
Reciprocal relationship from TLPPF graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from TLPPF graph: her strengthens our supply chain, reducing environmental impact while maxi…
Reciprocal relationship from TLX graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from TLX graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from TLX grap…
Actinium Pharmaceuticals, Inc. Customers
Ticker
Name
Confidence
Evidence
IMMEDICA-PHARMA-AB
IMMEDICA-PHARMA-AB
92%
Upon signing, the Company was entitled to an upfront, non-refundable payment of $ 35 million from Immedica, which was received in May 2022.
JONESTRADING-INSTITUTIONAL-SERVICES-LLC
JONESTRADING-INSTITUTIONAL-SERVICES-LLC
90%
In August 2020, the Company entered into the Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC, “JonesTrading”, pursuant to which the Company may sell, from time to time…
B-RILEY-SECURITIES-INC
B-RILEY-SECURITIES-INC
85%
On June 28, 2022, the Company entered into an Amended and Restated Capital on Demand™ Sales Agreement (the “A&R Sales Agreement”) with JonesTrading and B. Riley Securities, Inc. ("B. Riley").
GOVERNMENT-SPONSORED-ENTITY
GOVERNMENT-SPONSORED-ENTITY
80%
The Company has a grant from a government-sponsored entity for research and development related activities that provides for payments for reimbursed costs, which included overhead and general and adm…
Reciprocal relationship from DRTSW graph: o binding term sheets with Medison Pharma Ltd., one of the largest commercial partners of leading global biotech companies in international markets, and its …
eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatient-based care. As a result, we believe the majority of AML and High-risk MDS patien…
Reciprocal relationship from KURA graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from KURA graph: Reciprocal relationship from ATNM graph: eferred to and treated in comprehen…
Reciprocal relationship from MNPR graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from MNPR graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from MNPR g…
Reciprocal relationship from SNDX graph: Reciprocal relationship from ATNM graph: eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatien…
eferred to and treated in comprehensive treatment centers for in-patient treatment as opposed to community, outpatient-based care. As a result, we believe the majority of AML and High-risk MDS patien…
Reciprocal relationship from TLPPF graph: y ensures a steady and diverse supply of 177 Lu but also allows us to adapt quickly to changing market demands and regulatory environments. In addition to se…
Actinium Pharmaceuticals, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ATNM-DEBT
Debt stack $1.7M
90%
Market cache reports total debt of $1.7M.
ATNM-DEBT-7950
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2012-12-31.
ATNM-DEBT-7949
Warrants outstanding: 0.003
90%
xbrl warrant detail from xbrl 2022-12-31.
Actinium Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Actinium Pharmaceuticals, Inc..
Actinium Pharmaceuticals, Inc. Ownership
Holder
Name
Confidence
Evidence
ATNM-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 58 tracked holders.
Actinium Pharmaceuticals, Inc. Extended Supply Chain Network
